Rouba Kozak

Company: Novartis AG

Job title: Global Biomarker Diagnostic lead, Neuroscience

Seminars:

8.00 Tracking Neuropsychiatric Change as an Early Marker of Alzheimer’s Disease: Tangible Biomarkers & Symptoms 8:00 am

Exploring depression as an early marker of prodromal Alzheimer’s Disease to reflect disease pathology beyond amyloid and biological divergence Combining longitudinal omics data from patient cohorts with MDD to identify early markers of AD, determine AD susceptibility and identify risk factors within the patient populationRead more

day: Conference Day One

Panel Discussion: Multiomics, Longitudinal Data & Precision Medicine in the CNS: How Can we Get the Most Out of the Tools at Our Disposal? 9:00 am

Harnessing proteomics to identify early signatures of risk factors for neurodegenerative and neuroinflammatory disease Redefining disease heterogeneity with discrete biomarker populations Building up a network of internal and external capabilities to get the most out of complex patient data, producing quantitative biological insightsRead more

day: Conference Day One